Furthermore, subgroup analyses also indicated no significant association between elevated CD68+ TAMs density and RFS in bladder cancer patients, regardless of the CD68+ identified in whole sample area (or not specified), tumor stroma or tumor islet. The gene discussed is CD68; the disease is urinary bladder cancer.